Skip to content

Proteome Remodelling

Proteome Remodelling and Dynamics in Human Skeletal Muscle: Effect of Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04136457
Enrollment
72
Registered
2019-10-23
Start date
2019-10-30
Completion date
2023-11-28
Last updated
2023-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skeletal Muscle Physiology

Brief summary

The purpose of the project is to investigate the proteome signature dynamics and remodelling in human skeletal muscle induced by exercise training

Interventions

OTHEREndurance training

Subjects perform a period of endurance training

OTHERResistance training

Subjects perform a period of resistance training

Subjects perform a period of sprint training

Sponsors

Morten Hostrup, PhD
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men and women * VO2max \> 55 mL/min/kgLM for men and \> 50 for women (only applicable for endurance and sprint training interventions) * BMI \< 26

Exclusion criteria

* Chronic disease deemed by the medical doctor to pose a risk or to affect study outcomes * smoking * Use of prescription medicine deemed by the medical to affect study outcomes * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Anabolic signalingChange in anabolic signaling from rest to 1 hour following resistance exercise both at baseline and following 8 weeks of resistance trainingWestern blotting of proteins related to anabolic signaling
Skeletal muscle proteome signatureChange from baseline at week 6 or 8 depending on the interventionPathway enrichment analysis of the muscle proteome

Secondary

MeasureTime frameDescription
Maximal oxygen consumptionChange from baseline at week 6 following endurance and sprint trainingVO2max during incremental exercise
Body compositionChange from baseline at week 6 or 8 depending on the interventionLean and fat mass during dual X-ray absorptiometry
Satellite cellsChange from baseline at week 8 following resistance trainingImmunohistochemistry to determine number of satellite cells
Fiber sizeChange from baseline at week 8 following resistance trainingImmunohistochemistry to determine fiber size
MyonucleiChange from baseline at week 8 following resistance trainingImmunohistochemistry to determine number of myonuclei
Skeletal muscle mitochondrial respirationChange from baseline at week 6 following endurance and sprint trainingHigh resolution respirometry

Other

MeasureTime frameDescription
Skeletal muscle mitochondrial supercomplexesChange from baseline at week 6 following endurance and sprint trainingPathway enrichment analysis of mitochondrial supercomplexes

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026